Advertisement

Features

» immunology and drug development

Most Recent

image: Are the Kids Alright?

Are the Kids Alright?

By | March 1, 2012

Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?

6 Comments

image: Child-Proofing Drugs

Child-Proofing Drugs

By | March 1, 2012

When children need medications, getting the dosing and method of administration right is like trying to hit a moving target with an untried weapon.

6 Comments

image: The War Within

The War Within

By | February 1, 2012

Unraveling the molecular causes of acute pancreatitis—a potentially deadly disease in which the pancreas essentially digests itself—is yielding clues to how it might be treated.

12 Comments

image: Resolving Chronic Pain

Resolving Chronic Pain

By | January 1, 2012

The body’s own mechanism for dispersing the inflammatory reaction might lead to new treatments for chronic pain.

76 Comments

image: What Causes Alzheimer’s?

What Causes Alzheimer’s?

By | September 1, 2011

Researchers and pharma companies have tried to attack this disease by reducing amyloid plaques, but inflammation may be the real culprit.

39 Comments

Vaccines

By | June 1, 2011

Looking back, looking ahead

18 Comments

image: The Last Vaccine Frontier

The Last Vaccine Frontier

By | June 1, 2011

Successful vaccines have been created to protect against pathogenic bacteria and viruses. Why aren’t there any for combating fungal infections?

3 Comments

image: Recognizing the Human Potential

Recognizing the Human Potential

By | June 1, 2011

It may be time to reconsider an AIDS vaccine which is more human than viral, triggering the immune system in a way that no other vaccine does.

12 Comments

image: Shooting Down Addiction

Shooting Down Addiction

By | June 1, 2011

A new breed of vaccines aims to wean users off cocaine.

0 Comments

image: An Aspirin for your Cancer?

An Aspirin for your Cancer?

By | April 1, 2011

Can tumors—which can originate from, and often resemble, chronically inflamed tissue—be curtailed using familiar anti-inflammatory agents, without their side effects?

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement